HOME › DRUGS › CONCIZUMAB
ACTIVE SUBSTANCE / INN

CONCIZUMAB

Brand name(s): ALHEMO, Alhemo
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Hemophilia A;Hemophilia B
BLA761428
ACTIVE SUBSTANCE
Concizumab
REGULATORS
FDA · EMA
SPONSORS / MAH
Novo Nordisk A/S, NOVO NORDISK INC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ALHEMOBLA761428NOVO NORDISK INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AlhemoNovo Nordisk A/SAuthorised13/12/2024Hemophilia A;Hemophilia B

FULL INTELLIGENCE ON CONCIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →